Journal of Hepatology
Volume 49, Issue 2 , Pages 160-162, August 2008

Tumor-specific marker genes for intrahepatic cholangiocarcinoma: Utility and mechanistic insight☆☆☆

Miles and Shirley Fiterman Center for Digestive Diseases, Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA

published online 22 May 2008.

Associate Editor: J.M. Llovet

Keywords: Cholangiocarcinoma, Tumor markers, Carcinogenesis

Abbreviations: CCA, cholangiocarcinoma, ICC, intrahepatic cholangiocarcinoma, HCC, hepatocellular carcinoma, CLDN-4, chronic liver disease claudin-4, IGFBP-5, insulin-like growth factor-binding protein 5

No abstract is available. To read the body of this article, please view the Full Text online.

 

☆ The authors declare that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript. This work was supported by a grant from the NIH DK59427, the Mayo Clinic Clinical Investigator Program, and the Mayo Foundation.

☆☆ This work was supported by a grant from the NIH DK59427, the Mayo Clinic Clinical Investigator Program, and the Mayo Foundation.

PII: S0168-8278(08)00308-5

doi:10.1016/j.jhep.2008.05.001

Refers to article:

  • Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma , 06 May 2008

    Ryuhei Nishino, Masao Honda, Taro Yamashita, Hajime Takatori, Hiroshi Minato, Yoh Zen, Motoko Sasaki, Hiroyuki Takamura, Katsuhisa Horimoto, Tetsuo Ohta, Yasuni Nakanuma, Shuichi Kaneko
    Journal of Hepatology August 2008 (Vol. 49, Issue 2, Pages 207-216)

Journal of Hepatology
Volume 49, Issue 2 , Pages 160-162, August 2008

Article Tools